Product Information
GNP MULTI-SYMPTOM RLF EYE DROP is a generic product labeled by AmerisourceBergen, priced at $0.1968 per ML under NDC 46122075829. Its NADAC has been published 65 times since Nov 20, 2024.
GNP MULTI-SYMPTOM RLF EYE DROP
Polyethylene glycol 400, Tetrahydrozoline HCl, Zinc sulfateStrength
1; .05; .25 g/100mL; g/100mL; g/100mL
Manufacturer
AmerisourceBergenNDC
46122075829
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Last Updated
2/19/2025
Active Ingredients
POLYETHYLENE GLYCOL 400; TETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M018On Market Since
6/5/2023
Pharmacological Classes
Price Statistics
The NADAC for GNP MULTI-SYMPTOM RLF EYE DROP has been published 65 times since Nov 20, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1968 per ML |
|---|---|
| All-time high | $0.1968 (Feb 11, 2026) |
| All-time low | $0.1945 (Nov 20, 2024) |
| 52-week high | $0.1968 |
| 52-week low | $0.1968 |
| Median price | $0.1968 |
| Average price | $0.1965 |
| Largest weekly change | +0.6% (Feb 19, 2025) |
| Weeks tracked | 65 |
| Tracking since | Nov 20, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Polyethylene glycol 400, Tetrahydrozoline HCl, Zinc sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of GNP MULTI-SYMPTOM RLF EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for GNP MULTI-SYMPTOM RLF EYE DROP, manufactured by AmerisourceBergen, is $0.1968 per ML (NDC 46122075829), effective Feb 11, 2026.
How has the price of GNP MULTI-SYMPTOM RLF EYE DROP changed over time?
Over the history we have for it, the NADAC for GNP MULTI-SYMPTOM RLF EYE DROP has held within roughly two percent of its current level. It has been tracked across 65 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for GNP MULTI-SYMPTOM RLF EYE DROP?
Since Nov 20, 2024, the NADAC for GNP MULTI-SYMPTOM RLF EYE DROP has ranged from a low of $0.1945 (Nov 20, 2024) to a high of $0.1968 (Feb 11, 2026), with a median of $0.1968 per ML.
Are there cheaper alternatives to GNP MULTI-SYMPTOM RLF EYE DROP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of GNP MULTI-SYMPTOM RLF EYE DROP, so no direct lower-cost alternative is listed.
Who manufactures GNP MULTI-SYMPTOM RLF EYE DROP?
GNP MULTI-SYMPTOM RLF EYE DROP (NDC 46122075829) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.
Related Drugs
Same classification